Phoscan Chemical Cp (PCCLF) 0.1560 $PCCLF Wingren B.V.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phoscan Chemical Cp (PCCLF) 0.1560 $PCCLF

Wingren B.V. Files Early Warning Report
Marketwired - Tue Feb 02, 4:19PM CST
On February 2, 2016, Wingren B.V. ("NGP", c/o Prins Bernhardplein, 200, 1097 JB Amsterdam, The Netherlands, acquired ownership of 12,040,340 common shares ("New Petrus Shares" of Petrus Resources Ltd. (formerly known as Petrus Acquisition Corp.) ("New Petrus" pursuant to: (i) a plan of arrangement under section 193 of the Business Corporations Act (Alberta) (the "Arrangement" in accordance with the provisions of an arrangement agreement dated as of November 29, 2015, among Petrus Resources Corp. (formerly known as Petrus Resources Ltd.) ("Old Petrus", PhosCan Chemical Corp. ("PhosCan", New Petrus and Fox River Resources Corp.; and (ii) the completion of a private placement of subscription receipts to acquire New Petrus Shares ("New Petrus Subscription Receipts" upon completion of the Arrangement (the "Private Placement". NGP is owned, controlled or managed, directly or indirectly, by NGP Energy Capital Management.

Petrus Resources Announces Closing of Arrangement
Marketwired - Tue Feb 02, 4:09PM CST
Petrus Resources Ltd. ("Petrus" or the "Company" is pleased to announce that the previously announced plan of arrangement (the "Arrangement" involving Petrus, Petrus Resources Corp. ("Old Petrus", Petrus Resources Inc. (formerly PhosCan Chemical Corp.) ("PhosCan" and Fox River Resources Corporation ("Fox River" has closed, and aggregate gross proceeds from the previously announced $30 million bought deal financing (the "Financing" of subscription receipts of Petrus ("Subscription Receipts" have been released from escrow, resulting in aggregate gross proceeds to Petrus of approximately $75.4 million, inclusive of the gross proceeds of the Financing and the assumption of approximately $45.4 million of PhosCan's positive working capital.

PhosCan Granted Extension of TSX Delisting Review
Marketwired - Mon Nov 30, 4:22PM CST
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Toronto Stock Exchange ("TSX" has notified the Company that TSX has decided to extend its review of the eligibility of the Company's common shares for continued listing for a period of 60 days.
FOS.TO: 0.22 (-0.01)

IIROC Trade Resumption - Phoscan Chemical Corp.
Newsfile Corp - Mon Nov 30, 8:58AM CST
Trading resumes in:

IIROC Trade Halt - Phoscan Chemical Corp.
Newsfile Corp - Mon Nov 30, 8:36AM CST
The following issues have been halted by IIROC:

PhosCan Chemical Announces Results for Quarter Ended October 31, 2015
Marketwired - Thu Nov 19, 4:39PM CST
PhosCan Chemical Corp. (TSX: FOS) today released its quarterly results for the period ended October 31, 2015.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Provides Corporate Update
Marketwired - Fri Oct 23, 3:45PM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Board of Directors has decided not to accept the resignation of Mr. Gord McKinnon as a director of the Company. At the shareholders meeting held on July 28, 2015, Mr. McKinnon received fewer votes in favour of his re-election as a director than votes withheld. In accordance with the Company's Majority Voting Policy, Mr. McKinnon submitted his resignation to the Board, which resignation was subject to acceptance or rejection by the Board of Directors. Pursuant to the Policy, the Corporate Governance and Nominating Committee of the Company considered the resignation and made a recommendation to the Board. Both the Committee and the Board determined that, in light of Mr. McKinnon's involvement in the Company's ongoing strategic review process, it was not in the best interests of the Company or its shareholders for Mr. McKinnon to resign. Accordingly, the Board decided not to accept Mr. McKinnon's resignation, such that he will continue as a director of the Company. Mr. McKinnon did not participate in the consideration of his tendered resignation.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results for Quarter Ended July 31, 2015; Files Supplement to Information Circular
Marketwired - Fri Sep 11, 11:05AM CDT
(Expressed in Canadian Dollars)
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results of Annual and Special Meeting
Marketwired - Wed Jul 29, 7:40AM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces the results of its annual and special meeting of shareholders (the "Meeting" held in Toronto, Ontario on July 28, 2015.
FOS.TO: 0.22 (-0.01)

PhosCan Provides Update on Strategic Review Process and Announces TSX Delisting Review
Marketwired - Thu Jul 23, 6:01AM CDT
PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company" announces that the Toronto Stock Exchange (the "TSX" has notified the Company that the TSX is reviewing the Company's eligibility for continued listing, based on the Company's level of active business operations. For the past few years the Company has limited its expenditures on the Martison phosphate project due to market conditions. The Company is being reviewed under the TSX' Remedial Review Process and has 120 days to comply with all requirements for continued listing. If the Company cannot demonstrate that it meets all TSX continued listing requirements on or before November 23, 2015, the Company's securities will be delisted 30 days from such date. If the Company is unable to satisfy TSX requirements, it will seek a listing on another Canadian stock exchange.
FOS.TO: 0.22 (-0.01)

PhosCan Chemical Announces Results for Quarter Ended April 30, 2015
Marketwired - Fri Jun 12, 1:57PM CDT
PhosCan Chemical Corp. (TSX: FOS) today released its quarterly results for the period ended April 30, 2015.
FOS.TO: 0.22 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 99

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 27

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 235

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 335

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 254

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 148

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 489

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading